ACS–FCF Discovery Boost Grant supports researchers studying cancers associated with Fanconi anemia, funding translational work toward strategies for prevention, early detection, treatment, and cure.
Funder: Fanconi Cancer Foundation
Due Dates: December 1, 2026 (Application deadline)
Summary: Supports translational research focused on cancers associated with Fanconi anemia.
The ACS–FCF Discovery Boost Grant supports translational research focused on cancers associated with Fanconi anemia (FA). The Fanconi Cancer Foundation directs applicants to the American Cancer Society for this opportunity’s eligibility requirements, grant details, and application instructions.
The opportunity aligns with FCF’s cancer research focus. The foundation’s top research priority is to define the pathogenesis of Fanconi-associated cancers and develop strategies for prevention, early detection, treatment, and cure. More broadly, FCF supports interdisciplinary and translational research aimed at discovering and developing therapies or strategies to treat, control, or cure FA.